Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Indole | HCID 798 | — |
| Reactant | Melatonin | HCID 896 | — |
| Reactant | Tryptamine | HCID 1150 | — |
| Reactant | 1,3-Dibromopropane | HCID 8001 | — |
| Reactant | Phthalimide potassium salt | HCID 24194345 | — |
| Product | Bromopropylphthalimide | HCID 21958088 | — |
Reaction Steps
A method of synthesizing an indole derivative of the tryptamine type particularly melatonine, comprising the steps of 1) reacting potassium phthalimide and 1,3-di-bromopropane to obtain 3-bromopropylphthalimide; 2) reacting 3-bromopropylphthalimide with sodium acetoacetic ester in ethanol to obtain ethyl-2-acetyl-5-phthalimidopentanoate; 3) reacting the product from step 2) with diazo-p-anisidine to obtain 2-carboxyethyl-3-(2-phthalimidoethyl)-5-methoxy-indole; 4) reacting the 2-carboxyethyl-3-(2-phthalimidoethyl)-5-methoxy-indole with 2N/NaOH and then 20% H2SO4 to obtain impure 5-methoxytriptamine, which is purified by means of hexamethyldisilazane. The mono and disubstituted derivatives are obtained and the monosubstituted derivative is hydrolyzed with aqueous methanol and then recrystallized from ethanol. The N-acetyl derivative is prepared by reaction with acetic anhydride. Melatonine of high purity is obtained for prophylaxy and also against AIDS (Acquired Immuno Deficiency Syndrome).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05122535 |
|---|
| Source dataset | uspto-grants-1992_06 |
|---|
| ORD ID | ord-853ef2ff94ed4f2e8151f71e254e34b8 |
|---|
| Source note | uspto-grants-1992_06 |
|---|